Fmoc-L-Valine

Fmoc-L-Valine is an N-(9H-fluoren-9-ylmethoxycarbonyl)-protected L-valine amino acid in which the α-amino group is carbamated and the α-carboxyl group remains available for esterification or peptide coupling. The molecule contains the stereogenic center of L-valine, with a branched isopropyl side chain that imparts hydrophobic character and influences steric behavior during amide bond formation. The Fmoc group is base-labile, enabling orthogonal protection strategies in stepwise solid-phase or solution-phase peptide synthesis while minimizing interference from the side chain. The combination of a protected amine, free carboxyl functionality, and chiral backbone makes Fmoc-L-Valine a practical chiral building block and intermediate for downstream derivatization and peptide construction.

1. Peptide Synthesis

Fmoc-L-Valine is used in peptide building block preparation for both solid-phase and solution-phase peptide synthesis, where the Fmoc-protected α-amine supports controlled coupling cycles. The Fmoc carbamate masks the α-amino nucleophile, while the free carboxyl group participates in standard peptide coupling chemistry to form stable amide linkages. L-valine stereochemistry is retained through coupling, supporting stereochemically defined peptide sequences and minimizing epimerization risk under appropriate conditions. The resulting valine-containing peptide fragments can be extended to longer chains, enabling structure-activity relationship studies and sequence optimization in peptide science and peptidomimetic construction.

2. Protected Amino Acids

Fmoc-L-Valine serves as an N-protected amino acid intermediate for protected amino acid synthesis and orthogonal protection planning in multi-step synthetic routes. The Fmoc group provides a removable protecting strategy compatible with base-mediated deprotection, allowing iterative assembly while keeping the α-amino functionality protected between steps. The unmodified valine side chain remains chemically inert under many peptide synthesis conditions, which helps maintain side-chain integrity during N-deprotection and subsequent coupling. Downstream, Fmoc-L-Valine can be transformed into activated derivatives or used directly as a standardized chiral input for manufacturing-grade peptide intermediate preparation.

3. Chiral Building Block Development

Fmoc-L-Valine is suitable for chiral synthesis workflows that require a defined L-amino acid stereocenter and a protected amine handle for selective functional group manipulation. The molecule's chiral α-carbon and hydrophobic isopropyl side chain can influence stereochemical outcomes in derivative formation, including conversion to amino acid esters, amides, or side-chain-modified analogs. The Fmoc-protected nitrogen can be carried through synthetic steps as a stable protecting group, then removed when the protected amine is needed for subsequent coupling or conjugation. The resulting chiral amino acid derivatives support enantioselective fragment construction and stereochemically controlled intermediate generation for fine chemical synthesis.

4. Bioconjugation Chemistry

Fmoc-L-Valine can be applied in chemical biology and bioconjugation contexts as a valine-containing linker or as a precursor for peptide-based conjugates. The protected amino acid framework enables incorporation of a valine residue into short peptides that can be used as recognition elements, spacing units, or scaffold components for attaching biomolecules. The Fmoc strategy supports stepwise assembly of conjugation-ready peptides, where deprotection and coupling steps can be used to generate defined N-termini for subsequent functionalization. The hydrophobic valine side chain can modulate local conformation and solubility of conjugates, supporting downstream formation of biomolecule conjugates for analytical research and molecular recognition studies.

5. Pharmaceutical Manufacturing

Fmoc-L-Valine is used in pharmaceutical manufacturing supply chains for producing Fmoc-based peptide intermediates and sequence-defined fragments used in drug substance or drug product manufacturing workflows. The Fmoc-protected α-amino group and free carboxyl functionality enable consistent peptide coupling behavior, supporting reproducible preparation of valine-containing peptide building blocks. The stereochemical integrity of L-valine supports the formation of structurally defined intermediates that can be carried into further processing steps without introducing racemization-sensitive variability. The compound's compatibility with standard peptide synthesis infrastructure makes it relevant to process chemistry intermediate preparation and specialty chemical production requiring chiral amino acid inputs.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

3. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics